. 2022 Jun 30;10:e13643. doi: 10.7717/peerj.13643

Table 2. Somatic characteristics, biochemical indices and WBC and its specific subpopulations counts in the two study terms for two groups of women divided by the type of poles (RSA, n = 8 and NW, n = 15).

Parameters	Groups	Assessment at baseline (term I)	Assessment at the end (term II)
Body mass (kg)	RSA	69.70 ± 8.33	69.83 ± 8.47
Body mass (kg)	NW	67.23 ± 10.38	68.09 ± 10.37^**
BMI (kg/m²)	RSA	26.88 ± 3.46	26.96 ± 3.38
BMI (kg/m²)	NW	25.87 ± 3.41	26.21 ± 3.36^**
Fat mass (kg)	RSA	27.31 ± 6.30	26.30 ± 6.07^*
Fat mass (kg)	NW	27.00 ± 6.35	26.75 ± 6.34
Fat mass (%)	RSA	39.71 ± 5.08	38.69 ± 5.13^**
Fat mass (%)	NW	41.10 ± 4.47	40.67 ± 4.00
25(OH)D (ng/ml)	RSA	31.69 ± 14.32	32.24 ± 11.62
25(OH)D (ng/ml)	NW	24.51 ± 8.83	24.63 ± 9.74
Glucose (mmol/l)	RSA	5.12 ± 0.76	5.11 ± 0.68
Glucose (mmol/l)	NW	5.25 ± 0.42	5.36 ± 0.46
Insulin (µIU/ml)	RSA	16.07 ± 5.04	11.66 ± 5.67^*
Insulin (µIU/ml)	NW	14.86 ± 7.30	12.38 ± 6.79
HOMA-IR	RSA	3.68 ± 1.32	2.75 ± 1.65^*
HOMA-IR	NW	3.50 ± 1.81	2.97 ± 1.68
TC (mg/dl)	RSA	220.38 ± 35.62	197.38 ± 38.76^*
TC (mg/dl)	NW	204.13 ± 36.91	194.80 ± 44.57
TG (mg/dl)	RSA	100.63 ± 33.38	84.25 ± 28.32^*
TG (mg/dl)	NW	101.20 ± 71.11	95.00 ± 56.93
HDL-C (mg/dl)	RSA	66.71 ± 15.01	61.86 ± 11.25
HDL-C (mg/dl)	NW	62.11 ± 10.85	63.11 ± 11.83
LDL-C (mg/dl)	RSA	140.26 ± 45.93	141.38 ± 48.60
LDL-C (mg/dl)	NW	138.74 ± 37.81	137.54 ± 43.05
WBC (10⁹/l)	RSA	5.95 ± 1.24	5.50 ± 1.25
WBC (10⁹/l)	NW	6.57 ± 1.44	5.37 ± 1.31^**
LYM (10⁹/l)	RSA	2.17 ± 0.29	1.98 ± 0.40
LYM (10⁹/l)	NW	2.06 ± 0.67	1.81 ± 0.39^*
MON (10⁹/l)	RSA	0.43 ± 0.13	0.25 ± 0.05^**
MON (10⁹/l)	NW	0.47 ± 0.12	0.29 ± 0.07^**
GRA (10⁹/l)	RSA	3.35 ± 1.07	3.25 ± 1.08
GRA (10⁹/l)	NW	4.06 ± 1.10	3.28 ± 0.98^*

Notes.

Group RSA: poles with an integrated resistance shock absorber

Group NW: classic poles Results are expressed as mean ± SD

An asterisk (*) indicate p < 0.05, two asterisks (**) indicate p < 0.01; significant differences between the first and second terms of the study.